Navigation Links
Survey Sampling International Names Chris DeAngelis to Head New SSI Health
Date:3/15/2011

SHELTON, Conn., March 15, 2011 /PRNewswire/ -- Survey Sampling International (SSI)—the leading global provider of online and offline sampling solutions—has appointed Chris DeAngelis to head its new SSI Health business, created to support the unique sampling requirements of health-related market research projects.  Bringing SSI's 34-year legacy of sampling science to health-focused industries, SSI Health provides access to all major healthcare audiences—patients, caregivers, physicians and allied health professionals, including nurses/nurse practitioners, pharmacists, chiropractors and dentists.  Its reach extends across a range of therapeutic categories, including metabolic syndrome, central nervous system and mental health disorders, respiratory ailments and lifestyle treatments.

"Recognizing the unique challenges healthcare researchers face, SSI has created a dedicated team, focused on creating and delivering sample for health-related projects," says Mr. DeAngelis.  "As the treatment decision process becomes more complex and therapies become more specific, health-focused researchers must meet two conflicting goals—achieving greater reach to more audiences while supporting more precise targeting of lower-incidence populations.  With the advent of SSI Dynamix™—our game-changing dynamic sampling platform—SSI is uniquely able to fulfill both key requirements.  

"By linking to multiple sources—including our global online panels, as well as social media, affiliate partnerships, online communities and more—SSI can access anyone who wants to share opinions and experiences, even those who would never join a panel.  Plus, because we dynamically profile in real time— using multiple sets of refinement questions—we can recruit very specific segments to meet even the tightest parameters."

In addition to its online access, SSI Health offers the full spectrum of offline modes, including landline phone, mobile/wireless and Address-Based Sampling.  It also provides mixed access solutions, combining multiple modes.  By offering a range of data collection approaches, SSI ensures healthcare researchers can reach any audiences they need—even populations with rare conditions, segments not well covered by the Internet and patients in cell-only households.    

Chris DeAngelis Brings 25 Year of Sampling Experience to His New Role

Mr. DeAngelis brings 25 years of sampling expertise to his new role.  He first joined SSI in 1986 as an Account Executive and quickly moved up the ranks, rising to Senior Account Executive in 1991, National Sales Manager in 1997 and Vice President, Sales, North America in 2003.  

Mr. DeAngelis is a member of the MRA, AAPOR, PMRG and PBIRG.  He holds a BA in Economics from Bates College and an MBA in Marketing from the University of Bridgeport.  He also spent a year studying Economics in the UK.          

"Chris acts as a true partner to his customers, supporting them in creating the most effective sampling and survey designs," says Mark Hardy, SSI's Managing Director, Americas.  "His extensive experience across multiple industries, including healthcare, coupled with his deep understanding of sampling science make him the ideal candidate to lead SSI Health.  Chris brings the knowledge, experience and passion for methodological excellence to deliver optimal sampling solutions for health-related projects."

About Survey Sampling International

Survey Sampling International (www.surveysampling.com) is the premier global provider of sampling solutions for survey research. SSI reaches respondents in 72 countries via Internet, telephone and mobile/wireless.  Value-add services include questionnaire design consultation, programming and hosting, and data processing.  SSI serves more than 2,000 clients, including 48 of the top 50 research organizations. Founded in 1977, SSI has 17 offices in 15 countries.


'/>"/>
SOURCE Survey Sampling International (SSI)
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Reportlinker Adds Global Physician Survey on Stents, Stent-Grafts and Vulnerable Plaque Treatment 2011
2. Thats Nice LLC Launches Nice Insight Marketing Intelligence for CRAMs With Its Pharma & Biotech Outsourcing Survey
3. Survey Finds Patients Oppose Prescription Mandate for OTC Medicines Containing Pseudoephedrine
4. Sixty Percent of Surveyed Type 2 Diabetes Patients in the U.S. Who Use Insulin Indicate They Would Request a Switch to a Less Expensive Biosimilar Insulin if Such an Agent Became Available
5. On Average, 55 Percent of Surveyed U.S. Asthma Patients Say They Are Likely to Request a Switch to a Drug With Efficacy Comparable to Their Current Medication but Which is Dosed Just Once a Day
6. Reportlinker Adds Healthcare Reform: 2010 Medical Device Industry Perceptions Survey
7. A Majority of Surveyed PCPs and Endocrinologists Indicate that they will Prescribe Contrave, Lorqess and Qnexa if these Therapies are Approved for Obesity
8. Activity Against Key Drug-Resistant Pathogens is the Most Important Attribute Influencing Surveyed Physicians Antibiotic Selection for Nosocomial Pneumonia in the U.S.
9. Survey Reveals Majority of Americans Hold onto Myths About What Causes Colds and How to Treat Them
10. New Survey Highlights Immediate Need for Anesthesia Information Management Systems
11. For the Treatment of Rheumatoid Arthritis, Surveyed European Rheumatologists Expect Well-Established TNF-Alpha Inhibitors to Lose Considerable Patient Share to Newer Agents in This Drug Class
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/24/2016)... 2016   , Study ... overall bowel cleansing and superiority in , ... of the ascending colon ... Norgine B.V. today announced new positive data from the ... bowel preparation) versus standard 2 litre PEG with ascorbate. The study ...
(Date:5/24/2016)... N.J. , May 24, 2016 ... oncology drug development company, today provided an update ... dose escalating clinical trial combining GEN-1, the Company,s ... the treatment of newly-diagnosed patients with advanced ovarian ... interval debulking surgery.  GEN-1 is an IL-12 DNA ...
(Date:5/24/2016)... , May 24, 2016 ... ™ , la première endoprothèse ... cathéters destinés à l,intervention portant sur les ...   OrbusNeich, entreprise mondiale spécialisée ... de changer la vie, a élargi son ...
Breaking Medicine Technology:
(Date:5/25/2016)... (PRWEB) , ... May 25, 2016 , ... ... planning services and products in the developing world, is pleased to release their ... prevent over 5 million unwanted pregnancies, almost 14,000 maternal deaths and 3.8 million ...
(Date:5/25/2016)... , ... May 25, 2016 , ... ... Clearinghouse supporting the real time adjudication of medical service claims by Pharmacy Benefit ... their current medical claims management software. The TransactRx Cross Benefit Clearinghouse receives standard ...
(Date:5/25/2016)... ... , ... The University of San Francisco (USF) has named Margaret Wooding Baker ... of more than 100 full-time faculty and staff, and serve as a member of ... , Baker comes to USF from the University of Washington in Seattle, where she ...
(Date:5/25/2016)... ... May 25, 2016 , ... Laser Skin & Wellness Center ... hands of time of female aging. The Juliet™ procedure helps to ... such as leakage, laxity, itchiness and pain have reported real relief from these and ...
(Date:5/25/2016)... ... May 25, 2016 , ... Researchers from SUNY State ... Meeting for their work on visual evoked potential and human attention. The article, ... used the Diopsys® NOVA™ ERG and VEP Vision Testing System (Diopsys, Inc., ...
Breaking Medicine News(10 mins):